Search

Your search keyword '"Roobol M.J."' showing total 462 results

Search Constraints

Start Over You searched for: Author "Roobol M.J." Remove constraint Author: "Roobol M.J."
462 results on '"Roobol M.J."'

Search Results

1. Understanding the barriers to prostate cancer population-based early detection programs: The PRAISE-U BEST survey

3. Development of a predictive model for death amongst patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) treated with one of the approved treatment plans, on characteristics present at admission using Big data: Preliminary results from the European network of excellence for big data in prostate cancer (PIONEER)

6. Why is there a need to re-think prostate cancer early detection?

10. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium

11. Development of a prediction model in female pure or predominant urge urinary incontinence: a retrospective cohort study

12. Diagnostic and prognostic factors in patients with prostate cancer: a systematic review

13. Clinical characterization and outcomes of prostate cancer patients undergoing immediate vs. conservative management: A PIONEER study

15. Identification of pathologic factors associated with intraoperative positive surgical margins at NeuroSAFE for clinical decision-making on nerve-sparing surgery

18. Continence after introducing NeuroSAFE in radical prostatectomy

19. Mapping EAU guideline practice variations across Europe: An audit of ADT before surgery in locally advanced and high-risk prostate cancer in 6315 cases across 31 European countries

24. External validation of a model predicting increase in Gleason grade for men on Active Surveillance in the GAP3 consortium database

28. Cribriform and intraductal carcinoma do not improve the nomogram-based selection of prostate cancer patients for pelvic lymph node dissection

32. Secondary treatment for men with localized prostate cancer: A pooled analysis of PRIAS and ERSPC-Rotterdam datasets within the PIONEER data platform

33. A 2-arm pseudo-randomized multicenter (MR PROPER) trial: MRI-directed pathway outperforms TRUS-directed pathway in prostate cancer diagnosis following upfront risk stratification

37. Prostate cancer specific mortality in the ERSPC trial: What is the role of screening result and adherence

39. Diagnostic and prognostic factors in patients with prostate cancer

41. Outcomes after introducing intraoperative NeuroSAFE technique in robot-assisted radical prostatectomy

45. The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer

46. IMAGINE-IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines

47. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission

48. Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renee Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy

49. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.

50. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0).

Catalog

Books, media, physical & digital resources